| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8603874 | The American Journal of Medicine | 2018 | 11 Pages |
Abstract
There is a dire need for novel treatment options for nonalcoholic fatty liver disease to prevent progression to cirrhosis. Reduction of liver fat by d-amphetamine suggests a potential therapeutic role in nonalcoholic fatty liver disease.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sehem MD, Jawad MD, Elle MD, PhD, Irbaz Bin MD, Bobby MD, Karen L. PhD, MD,